Cryptococcosis in patients with diabetes mellitus II in mainland China: 1993‐2015
Abstract
Summary: Diabetes mellitus II (DM II) is a newly defined independent factor contributing to the morbidity and mortality of cryptococcosis. This retrospective case analysis aims to explore the epidemiology, clinical profile and strain characteristics of cryptococcosis in Chinese DM II patients. This study included 30 cases of cryptococcosis with DM II occurring from 1993 to 2015 in mainland China. The hospital‐based prevalence of cryptococcosis in DM II was 0.21%. The mean age of the patients was 56.1 years (95% confidence interval: 51.5, 60.6), and 93% of the patients were older than 40 years. Sixty‐two per cent of the patients experienced untreated or poorly controlled blood glucose before infection. Multilocus sequence typing analysis categorised all cultured strains as Cryptococcus neoformans and sequence type 5. Sixty‐nine per cent of pulmonary cryptococcosis patients experienced misdiagnoses and treatment delays. Sixty per cent of cryptococcal meningitis patients received substandard antifungal therapy. The overall death rate was 33%. Considering the large population size of DM II patients in China, improved attention should be paid to the high prevalence of cryptococcosis as revealed by us. We also emphasised the importance of blood glucose control for infection prevention, especially among the elderly.Keywords
Funding Information
- Second Military Medical University (2017JZ49)
- National Natural Science Foundation of China (81201269, 31270180)
- Science and Technology Commission of Shanghai Municipality (14DZ2272900, 14495800500)
This publication has 32 references indexed in Scilit:
- Geographically Structured Populations of Cryptococcus neoformans Variety grubii in Asia Correlate with HIV Status and Show a Clonal Population StructurePLOS ONE, 2013
- Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and VoriconazoleAntimicrobial Agents and Chemotherapy, 2012
- Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Amphotericin B and FlucytosineAntimicrobial Agents and Chemotherapy, 2012
- Cryptococcus gattii in the United States: Clinical Aspects of Infection With an Emerging PathogenClinical Infectious Diseases, 2011
- Aging of the innate immune systemCurrent Opinion in Immunology, 2010
- Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2010
- Cryptococcus neoformansmeningitis in a diabetic patient - the perils of an overzealous immune response: a case reportCases Journal, 2009
- Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDSAIDS, 2009
- Consensus multi-locus sequence typing scheme forCryptococcus neoformansandCryptococcus gattiiMedical Mycology, 2009
- Infections withCryptococcus neoformansin the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1989